LACTULOSE

LACTULOSE was reported 38639 times

LACTULOSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 53 0.5521
1 FEMORAL HERNIA INCARCERATED 28 0.3889
2 TOTAL LUNG CAPACITY INCREASED 98 0.3603
3 LYMPHATIC FISTULA 29 0.2900
4 SEDATION COMPLICATION 554 0.2169
5 PROLONGED EXPIRATION 54 0.2061
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 99 0.1893
7 CREATININE RENAL CLEARANCE DECREASED 558 0.1393
8 AMMONIA INCREASED 654 0.1281
9 MULTIPLE DRUG THERAPY 91 0.1207
10 NAIL BED INFLAMMATION 37 0.1160
11 PANCREATIC STEATOSIS 28 0.1029
12 WOUND INFECTION PSEUDOMONAS 32 0.1022
13 VASCULAR ENCEPHALOPATHY 28 0.0986
14 HEPATIC ENCEPHALOPATHY 852 0.0912
15 SKIN CANDIDA 43 0.0824
16 AMMONIA ABNORMAL 33 0.0819
17 CREATININE RENAL CLEARANCE INCREASED 61 0.0816
18 CARDIOSPASM 43 0.0771
19 CIRRHOSIS ALCOHOLIC 35 0.0764
20 PORTAL HYPERTENSIVE GASTROPATHY 43 0.0762
21 NASAL MUCOSAL DISORDER 40 0.0686
22 IMMUNISATION 29 0.0668
23 PALMOPLANTAR KERATODERMA 44 0.0607
24 BLOOD CALCIUM DECREASED 606 0.0538
25 JAUNDICE CHOLESTATIC 189 0.0535
26 HYPOMANIA 175 0.0475
27 ORTHOSTATIC HYPOTENSION 809 0.0464
28 VARICES OESOPHAGEAL 139 0.0459
29 STREPTOCOCCAL SEPSIS 51 0.0430
30 HEPATORENAL SYNDROME 67 0.0397
31 OESOPHAGEAL VARICES HAEMORRHAGE 83 0.0382
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 39 0.0367
33 FAECALOMA 191 0.0348
34 PSEUDOMONAL SEPSIS 59 0.0337
35 AORTIC ARTERIOSCLEROSIS 86 0.0334
36 SYSTEMIC INFECTION 52 0.0313
37 HYPERAMMONAEMIC ENCEPHALOPATHY 51 0.0293
38 NEPHROGENIC ANAEMIA 131 0.0283
39 ASTERIXIS 30 0.0282
40 PNEUMATOSIS INTESTINALIS 79 0.0277
41 INABILITY TO AFFORD MEDICATION 270 0.0272
42 HEPATIC CIRRHOSIS 510 0.0271
43 PORTAL HYPERTENSION 83 0.0269
44 ARTERIAL HAEMORRHAGE 30 0.0262
45 INTESTINAL DILATATION 35 0.0262
46 SEROMA 33 0.0259
47 HYPERPARATHYROIDISM SECONDARY 65 0.0259
48 SEDATION 677 0.0258
49 HYPERAMMONAEMIA 118 0.0236
50 RHINITIS ALLERGIC 105 0.0236
51 SCHIZOPHRENIA 283 0.0233
52 NEUTROPENIC SEPSIS 166 0.0232
53 MESOTHELIOMA 30 0.0231
54 ATRIAL TACHYCARDIA 48 0.0228
55 SARCOIDOSIS 105 0.0221
56 CLEFT PALATE 42 0.0217
57 ABDOMINAL TENDERNESS 107 0.0215
58 VASCULAR DEVICE INFECTION 94 0.0207
59 ANTIPSYCHOTIC DRUG LEVEL INCREASED 58 0.0206
60 STOMA SITE ERYTHEMA 38 0.0203
61 NASAL POLYPS 100 0.0203
62 SUBILEUS 42 0.0202
63 MUTISM 29 0.0200
64 DEPRESSED LEVEL OF CONSCIOUSNESS 761 0.0192
65 BRONCHIECTASIS 129 0.0191
66 PRURITUS GENITAL 45 0.0191
67 MONOCYTE COUNT INCREASED 69 0.0190
68 HYPERNATRAEMIA 94 0.0188
69 STOMA SITE DISCHARGE 51 0.0186
70 INTRA-ABDOMINAL FLUID COLLECTION 33 0.0184
71 RENAL FUNCTION TEST ABNORMAL 85 0.0183
72 COGNITIVE DISORDER 846 0.0181
73 ASCITES 514 0.0175
74 AORTIC VALVE STENOSIS 31 0.0174
75 THERAPEUTIC AGENT TOXICITY 57 0.0171
76 DEPRESSIVE SYMPTOM 60 0.0170
77 BLOOD BILIRUBIN INCREASED 457 0.0169
78 CARDIAC MURMUR 146 0.0169
79 REBOUND ACID HYPERSECRETION 49 0.0162
80 HEPATIC FAILURE 486 0.0161
81 RALES 93 0.0160
82 LIVER TRANSPLANT 56 0.0154
83 ON AND OFF PHENOMENON 85 0.0153
84 INSURANCE ISSUE 232 0.0152
85 DIVERTICULUM INTESTINAL 66 0.0151
86 BILIRUBIN CONJUGATED INCREASED 35 0.0150
87 ARTERIOSCLEROSIS CORONARY ARTERY 99 0.0149
88 NEUTROPHIL COUNT INCREASED 150 0.0146
89 RED CELL DISTRIBUTION WIDTH INCREASED 60 0.0144
90 ILEUS 175 0.0141
91 END STAGE RENAL DISEASE 256 0.0140
92 HEPATIC CYST 47 0.0138
93 FREEZING PHENOMENON 51 0.0138
94 ABDOMINAL RIGIDITY 37 0.0136
95 DUODENAL ULCER HAEMORRHAGE 39 0.0136
96 CLOSTRIDIUM TEST POSITIVE 30 0.0136
97 HAEMATEMESIS 342 0.0135
98 HEPATIC NEOPLASM MALIGNANT 28 0.0132
99 TOXIC EPIDERMAL NECROLYSIS 198 0.0130
100 PORTAL VEIN THROMBOSIS 42 0.0130
101 BLOOD ALBUMIN DECREASED 99 0.0125
102 FAILURE TO THRIVE 64 0.0123
103 VOLVULUS 29 0.0122
104 TENSION HEADACHE 52 0.0121
105 APPETITE DISORDER 80 0.0121
106 CAROTID ARTERY OCCLUSION 44 0.0120
107 INFREQUENT BOWEL MOVEMENTS 30 0.0120
108 HYPONATRAEMIA 677 0.0120
109 METABOLIC ENCEPHALOPATHY 36 0.0120
110 CONSTIPATION 2603 0.0119
111 FUNCTIONAL GASTROINTESTINAL DISORDER 41 0.0118
112 ENCEPHALOPATHY 291 0.0118
113 HEPATOCELLULAR CARCINOMA 89 0.0117
114 WOUND DEHISCENCE 39 0.0115
115 APLASTIC ANAEMIA 60 0.0115
116 CHOLELITHIASIS 376 0.0115
117 UPPER GASTROINTESTINAL HAEMORRHAGE 192 0.0114
118 SLEEP TERROR 48 0.0114
119 ESCHERICHIA SEPSIS 33 0.0114
120 BALANCE DISORDER 982 0.0113
121 TACHYARRHYTHMIA 28 0.0112
122 ILEUS PARALYTIC 50 0.0112
123 DECUBITUS ULCER 90 0.0110
124 MOBILITY DECREASED 787 0.0109
125 HYPERKALAEMIA 384 0.0109
126 FLANK PAIN 101 0.0108
127 TRICUSPID VALVE INCOMPETENCE 85 0.0107
128 ATELECTASIS 103 0.0106
129 RESPIRATION ABNORMAL 73 0.0106
130 GASTROINTESTINAL SOUNDS ABNORMAL 52 0.0105
131 VARICOSE VEIN 54 0.0104
132 HEPATOTOXICITY 231 0.0104
133 ENTEROCOCCAL INFECTION 50 0.0103
134 FEMORAL NECK FRACTURE 53 0.0103
135 ESCHERICHIA INFECTION 85 0.0103
136 PARONYCHIA 45 0.0102
137 HYPERVOLAEMIA 50 0.0101
138 CACHEXIA 52 0.0101
139 PSYCHOTIC DISORDER 298 0.0101
140 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
141 BRONCHOPNEUMONIA 34 0.0099
142 HYPOALBUMINAEMIA 77 0.0099
143 ESCHERICHIA URINARY TRACT INFECTION 42 0.0099
144 MULTIPLE MYELOMA 46 0.0099
145 LUNG NEOPLASM 42 0.0098
146 THROMBOCYTOSIS 36 0.0098
147 IRON DEFICIENCY 44 0.0098
148 RENAL FAILURE CHRONIC 75 0.0097
149 IRON DEFICIENCY ANAEMIA 90 0.0097
150 SPLENOMEGALY 114 0.0097
151 JAUNDICE 261 0.0097
152 MENTAL STATUS CHANGES 268 0.0096
153 OESOPHAGEAL ULCER 37 0.0096
154 HYDRONEPHROSIS 72 0.0096
155 NEPHROGENIC SYSTEMIC FIBROSIS 29 0.0096
156 HYPOKALAEMIA 441 0.0095
157 CEREBRAL ATROPHY 38 0.0095
158 BENIGN PROSTATIC HYPERPLASIA 49 0.0095
159 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
160 COMMUNICATION DISORDER 36 0.0094
161 CONFUSIONAL STATE 1514 0.0094
162 MELAENA 206 0.0094
163 BLOOD CULTURE POSITIVE 28 0.0093
164 PROTEIN TOTAL DECREASED 35 0.0093
165 KLEBSIELLA INFECTION 47 0.0093
166 OESOPHAGITIS 101 0.0092
167 PERITONITIS BACTERIAL 93 0.0092
168 HEPATIC NEOPLASM 30 0.0092
169 SMALL INTESTINAL OBSTRUCTION 113 0.0092
170 BRADYKINESIA 54 0.0091
171 ASPIRATION 100 0.0091
172 NEUROLEPTIC MALIGNANT SYNDROME 108 0.0091
173 UROSEPSIS 84 0.0091
174 PROTHROMBIN TIME PROLONGED 54 0.0090
175 HEPATITIS C 108 0.0089
176 LYMPHOCYTE COUNT DECREASED 158 0.0089
177 HYPOPHOSPHATAEMIA 66 0.0089
178 HAEMATOCRIT DECREASED 174 0.0088
179 METASTASES TO LYMPH NODES 59 0.0087
180 SPINAL CORD COMPRESSION 34 0.0087
181 HIATUS HERNIA 112 0.0086
182 COLITIS ISCHAEMIC 58 0.0086
183 LIVER FUNCTION TEST ABNORMAL 247 0.0085
184 RHINOVIRUS INFECTION 33 0.0085
185 SKIN ABRASION 40 0.0085
186 BLADDER DISORDER 84 0.0085
187 SPUTUM DISCOLOURED 80 0.0084
188 PROSTATE CANCER METASTATIC 28 0.0084
189 PNEUMONIA ASPIRATION 207 0.0083
190 HYPOVOLAEMIA 48 0.0082
191 DELIRIUM 284 0.0082
192 HEPATITIS ACUTE 53 0.0081
193 TOXIC ENCEPHALOPATHY 41 0.0081
194 ACUTE KIDNEY INJURY 1238 0.0081
195 DUODENAL ULCER 57 0.0081
196 UNRESPONSIVE TO STIMULI 208 0.0081
197 BLOOD ALKALINE PHOSPHATASE INCREASED 200 0.0080
198 HYPERURICAEMIA 33 0.0080
199 AZOTAEMIA 32 0.0080
200 BLOOD SODIUM DECREASED 150 0.0079
201 URINARY RETENTION 265 0.0079
202 HYPOTENSION 1581 0.0079
203 FEBRILE NEUTROPENIA 522 0.0079
204 ACUTE RESPIRATORY FAILURE 150 0.0078
205 MUSCLE RIGIDITY 93 0.0078
206 FEBRILE BONE MARROW APLASIA 33 0.0078
207 GENERAL PHYSICAL HEALTH DETERIORATION 897 0.0077
208 FAECES HARD 30 0.0077
209 CANDIDA INFECTION 130 0.0077
210 HYPOMAGNESAEMIA 107 0.0077
211 PATHOLOGICAL FRACTURE 39 0.0077
212 INFLAMMATORY MARKER INCREASED 38 0.0077
213 BLOOD PHOSPHORUS DECREASED 28 0.0077
214 GASTROINTESTINAL MOTILITY DISORDER 41 0.0077
215 BLOOD MAGNESIUM DECREASED 66 0.0076
216 MITRAL VALVE INCOMPETENCE 86 0.0076
217 HOSPICE CARE 75 0.0076
218 WHITE BLOOD CELL COUNT INCREASED 291 0.0076
219 INGUINAL HERNIA 46 0.0076
220 HYPERBILIRUBINAEMIA 78 0.0075
221 HYPERTRIGLYCERIDAEMIA 44 0.0075
222 ELECTROLYTE IMBALANCE 87 0.0075
223 CANDIDIASIS 30 0.0075
224 INTESTINAL ISCHAEMIA 41 0.0074
225 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165 0.0074
226 MALNUTRITION 83 0.0074
227 MUCOSAL INFLAMMATION 194 0.0074
228 CIRCULATORY COLLAPSE 126 0.0074
229 SUBARACHNOID HAEMORRHAGE 75 0.0074
230 POLYDIPSIA 29 0.0073
231 PLEURAL EFFUSION 446 0.0073
232 BLOOD UREA INCREASED 122 0.0073
233 FAECAL INCONTINENCE 35 0.0073
234 BRAIN OEDEMA 92 0.0073
235 HYPOPHAGIA 186 0.0073
236 POSTOPERATIVE WOUND INFECTION 49 0.0072
237 OLIGURIA 45 0.0072
238 CYTOKINE RELEASE SYNDROME 145 0.0072
239 FLUID OVERLOAD 105 0.0072
240 HYPOTHERMIA 73 0.0072
241 SEPSIS 804 0.0072
242 URINE OUTPUT DECREASED 63 0.0072
243 GENERALISED OEDEMA 89 0.0072
244 NEUROLOGICAL SYMPTOM 41 0.0072
245 RENAL FAILURE ACUTE 301 0.0071
246 COMPRESSION FRACTURE 38 0.0071
247 ABNORMAL FAECES 58 0.0071
248 GROIN PAIN 62 0.0071
249 FACIAL PAIN 63 0.0071
250 HAEMORRHAGIC ANAEMIA 31 0.0070
251 AORTIC VALVE INCOMPETENCE 30 0.0070
252 LEG AMPUTATION 29 0.0070
253 RENAL TUBULAR NECROSIS 69 0.0070
254 ACUTE HEPATIC FAILURE 96 0.0070
255 HEPATOMEGALY 69 0.0070
256 LOWER RESPIRATORY TRACT INFECTION 319 0.0070
257 LEFT VENTRICULAR HYPERTROPHY 30 0.0070
258 FALL 2323 0.0070
259 TRANSFUSION 73 0.0070
260 CORONARY ARTERY STENOSIS 35 0.0070
261 PULMONARY HYPERTENSION 144 0.0069
262 CHRONIC KIDNEY DISEASE 523 0.0069
263 NEUTROPHIL COUNT DECREASED 280 0.0069
264 ANURIA 59 0.0068
265 UMBILICAL HERNIA 32 0.0068
266 GRANULOCYTOPENIA 39 0.0068
267 BLOOD CALCIUM INCREASED 60 0.0068
268 HAEMORRHOIDS 133 0.0068
269 RENAL CYST 54 0.0068
270 DEMENTIA 190 0.0068
271 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 37 0.0068
272 INCOHERENT 44 0.0068
273 DEHYDRATION 903 0.0068
274 AUTOIMMUNE HEPATITIS 47 0.0068
275 BREATH SOUNDS ABNORMAL 33 0.0067
276 BACTERAEMIA 79 0.0066
277 GASTRITIS 174 0.0066
278 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 345 0.0066
279 MYOCARDIAL ISCHAEMIA 75 0.0066
280 HAEMOGLOBIN INCREASED 30 0.0066
281 C-REACTIVE PROTEIN INCREASED 239 0.0066
282 SPINAL COLUMN STENOSIS 31 0.0066
283 HYPERCALCAEMIA 81 0.0066
284 SINUS TACHYCARDIA 93 0.0065
285 DISORIENTATION 259 0.0065
286 HAEMOGLOBIN DECREASED 671 0.0065
287 CARDIOMEGALY 80 0.0065
288 SEPTIC SHOCK 282 0.0065
289 ANAL INCONTINENCE 58 0.0064
290 OEDEMA PERIPHERAL 785 0.0064
291 ABDOMINAL DISTENSION 672 0.0064
292 METASTASES TO CENTRAL NERVOUS SYSTEM 83 0.0064
293 MULTI-ORGAN FAILURE 111 0.0064
294 DROOLING 44 0.0064
295 VASCULITIS 74 0.0063
296 HAEMORRHOIDAL HAEMORRHAGE 31 0.0063
297 STAPHYLOCOCCAL SEPSIS 31 0.0063
298 SPINAL OSTEOARTHRITIS 55 0.0063
299 URINARY INCONTINENCE 185 0.0062
300 INCONTINENCE 66 0.0062
301 JOINT DISLOCATION 66 0.0062
302 LIVER DISORDER 276 0.0062
303 FLUID INTAKE REDUCED 31 0.0062
304 ANAEMIA 1173 0.0061
305 SUBDURAL HAEMATOMA 88 0.0061
306 ATRIOVENTRICULAR BLOCK COMPLETE 41 0.0061
307 SALIVARY HYPERSECRETION 61 0.0061
308 BLOOD POTASSIUM INCREASED 99 0.0061
309 INTERNATIONAL NORMALISED RATIO INCREASED 173 0.0061
310 GASTRITIS EROSIVE 28 0.0060
311 RASH VESICULAR 29 0.0060
312 VENTRICULAR TACHYCARDIA 99 0.0060
313 HICCUPS 49 0.0060
314 HALLUCINATION, VISUAL 126 0.0060
315 PETECHIAE 62 0.0059
316 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
317 DERMATITIS BULLOUS 43 0.0059
318 BRADYCARDIA 315 0.0059
319 RECTAL HAEMORRHAGE 255 0.0059
320 POLYNEUROPATHY 71 0.0059
321 ORAL CANDIDIASIS 78 0.0059
322 TROPONIN INCREASED 45 0.0059
323 BOWEL MOVEMENT IRREGULARITY 45 0.0059
324 URINARY TRACT INFECTION 1001 0.0059
325 CELLULITIS 295 0.0058
326 GASTROINTESTINAL HAEMORRHAGE 489 0.0058
327 PREMATURE LABOUR 33 0.0058
328 PLATELET COUNT INCREASED 76 0.0058
329 ATAXIA 69 0.0058
330 RED BLOOD CELL COUNT DECREASED 166 0.0058
331 LEUKOCYTOSIS 105 0.0058
332 RENAL FAILURE 767 0.0058
333 LETHARGY 332 0.0058
334 FAECES DISCOLOURED 125 0.0058
335 HALLUCINATION 434 0.0058
336 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 59 0.0057
337 PARKINSONISM 56 0.0057
338 ABDOMINAL PAIN 1335 0.0057
339 COAGULOPATHY 95 0.0057
340 OSTEOPENIA 86 0.0057
341 BLOOD POTASSIUM DECREASED 170 0.0056
342 RESPIRATORY DISTRESS 156 0.0056
343 WHEEZING 335 0.0056
344 PLATELET COUNT DECREASED 602 0.0056
345 CHOLANGITIS 35 0.0056
346 SUPRAVENTRICULAR TACHYCARDIA 54 0.0056
347 DYSARTHRIA 212 0.0056
348 LIPASE INCREASED 43 0.0056
349 ELECTROCARDIOGRAM ABNORMAL 44 0.0056
350 LACTIC ACIDOSIS 181 0.0056
351 SPINAL COMPRESSION FRACTURE 46 0.0056
352 MUSCLE TWITCHING 128 0.0055
353 MOUTH ULCERATION 117 0.0055
354 ANGINA PECTORIS 159 0.0055
355 INTESTINAL OBSTRUCTION 209 0.0055
356 BLOOD URIC ACID INCREASED 32 0.0055
357 PANCYTOPENIA 309 0.0055
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 156 0.0055
359 MYOCARDITIS 63 0.0055
360 ACIDOSIS 42 0.0055
361 STEVENS-JOHNSON SYNDROME 122 0.0055
362 MYOSITIS 49 0.0055
363 PERITONITIS 113 0.0055
364 DIALYSIS 77 0.0054
365 PNEUMONIA 1755 0.0054
366 THROMBOCYTOPENIA 605 0.0054
367 BLOOD CREATININE INCREASED 352 0.0054
368 EXERCISE TOLERANCE DECREASED 31 0.0054
369 TERMINAL STATE 36 0.0054
370 MOUTH SWELLING 31 0.0054
371 ODYNOPHAGIA 32 0.0054
372 RIB FRACTURE 110 0.0053
373 LARGE INTESTINE PERFORATION 37 0.0053
374 HYPOXIA 187 0.0053
375 SERUM FERRITIN INCREASED 28 0.0053
376 TACHYPNOEA 72 0.0053
377 CHOLECYSTITIS ACUTE 30 0.0053
378 THERAPY INTERRUPTED 378 0.0053
379 HYPERGLYCAEMIA 192 0.0053
380 EMPHYSEMA 53 0.0052
381 OEDEMA 284 0.0052
382 HYPOCALCAEMIA 99 0.0052
383 HAEMATURIA 179 0.0052
384 CARDIOGENIC SHOCK 75 0.0052
385 DELUSION 81 0.0052
386 EJECTION FRACTION DECREASED 81 0.0052
387 MYOPATHY 45 0.0052
388 REFUSAL OF TREATMENT BY PATIENT 34 0.0052
389 LYMPHOEDEMA 36 0.0052
390 MYOCLONUS 62 0.0052
391 METASTASES TO LUNG 60 0.0052
392 DYSKINESIA 211 0.0052
393 RESTLESSNESS 190 0.0052
394 SHOCK HAEMORRHAGIC 42 0.0052
395 PULMONARY OEDEMA 231 0.0052
396 ECONOMIC PROBLEM 78 0.0051
397 ALANINE AMINOTRANSFERASE INCREASED 316 0.0051
398 PSEUDOMONAS INFECTION 44 0.0051
399 POLYURIA 42 0.0051
400 RESPIRATORY FAILURE 374 0.0051
401 GLOMERULAR FILTRATION RATE DECREASED 63 0.0051
402 HEPATIC STEATOSIS 95 0.0051
403 LUNG INFILTRATION 45 0.0051
404 PRODUCTIVE COUGH 242 0.0051
405 LEUKOPENIA 253 0.0051
406 ELECTROCARDIOGRAM QT PROLONGED 181 0.0050
407 HAEMARTHROSIS 45 0.0050
408 DRUG INTERACTION 794 0.0050
409 HAEMODIALYSIS 42 0.0050
410 DYSPNOEA EXERTIONAL 188 0.0050
411 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0050
412 ECCHYMOSIS 34 0.0050
413 GASTROOESOPHAGEAL REFLUX DISEASE 399 0.0050
414 LIP SWELLING 165 0.0049
415 CHOLECYSTITIS 59 0.0049
416 IMPAIRED GASTRIC EMPTYING 67 0.0049
417 SUDDEN DEATH 52 0.0049
418 INTESTINAL PERFORATION 55 0.0049
419 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 29 0.0049
420 TOXICITY TO VARIOUS AGENTS 825 0.0049
421 TUMOUR LYSIS SYNDROME 43 0.0049
422 RHABDOMYOLYSIS 203 0.0049
423 MYELODYSPLASTIC SYNDROME 70 0.0048
424 HAEMORRHAGE INTRACRANIAL 72 0.0048
425 CARDIOMYOPATHY 71 0.0048
426 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 81 0.0048
427 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
428 DYSPHAGIA 451 0.0047
429 AGRANULOCYTOSIS 88 0.0047
430 UPPER RESPIRATORY TRACT INFECTION 218 0.0047
431 FEELING DRUNK 35 0.0047
432 MOTOR DYSFUNCTION 48 0.0047
433 NOCTURIA 57 0.0047
434 BLOOD LACTATE DEHYDROGENASE INCREASED 74 0.0047
435 NEUTROPENIA 635 0.0047
436 HAEMOPTYSIS 130 0.0047
437 ASPARTATE AMINOTRANSFERASE INCREASED 246 0.0046
438 PRODUCT SUPPLY ISSUE 33 0.0046
439 VOMITING 2172 0.0046
440 LARGE INTESTINE POLYP 32 0.0046
441 DEVICE RELATED INFECTION 71 0.0046
442 HYPERLIPIDAEMIA 55 0.0046
443 MENTAL IMPAIRMENT 111 0.0046
444 LUNG INFECTION 71 0.0046
445 PNEUMONITIS 124 0.0045
446 GRAND MAL CONVULSION 42 0.0045
447 TUBULOINTERSTITIAL NEPHRITIS 85 0.0045
448 HAEMOLYSIS 35 0.0045
449 DRUG LEVEL INCREASED 75 0.0045
450 CARDIAC FAILURE ACUTE 30 0.0045
451 APHASIA 136 0.0045
452 RESPIRATORY TRACT INFECTION 117 0.0045
453 PULMONARY CONGESTION 59 0.0045
454 SINUS BRADYCARDIA 43 0.0044
455 METASTASES TO LIVER 78 0.0044
456 RIGHT VENTRICULAR FAILURE 31 0.0044
457 RENAL IMPAIRMENT 369 0.0044
458 APPENDICITIS 41 0.0044
459 ENTERITIS 28 0.0044
460 HEPATIC ENZYME INCREASED 298 0.0044
461 APNOEA 34 0.0044
462 PELVIC FRACTURE 34 0.0044
463 AORTIC ANEURYSM 33 0.0043
464 TORSADE DE POINTES 34 0.0043
465 ORAL PAIN 97 0.0043
466 PRODUCT PRESCRIBING ERROR 103 0.0043
467 EATING DISORDER 92 0.0043
468 TACHYCARDIA 383 0.0043
469 ALTERED STATE OF CONSCIOUSNESS 93 0.0043
470 MUSCULOSKELETAL CHEST PAIN 66 0.0043
471 TREATMENT NONCOMPLIANCE 233 0.0043
472 BLOOD DISORDER 34 0.0042
473 DECREASED APPETITE 982 0.0042
474 OBSTRUCTIVE AIRWAYS DISORDER 47 0.0042
475 SEIZURE 488 0.0042
476 ADRENAL INSUFFICIENCY 51 0.0042
477 LOWER GASTROINTESTINAL HAEMORRHAGE 31 0.0042
478 DRUG TOXICITY 57 0.0042
479 DYSURIA 154 0.0042
480 CARDIAC ARREST 345 0.0042
481 HAEMATOMA 108 0.0042
482 CHOLESTASIS 80 0.0042
483 EOSINOPHILIA 73 0.0042
484 PYREXIA 1441 0.0042
485 RESPIRATORY DEPRESSION 51 0.0042
486 NEURALGIA 101 0.0041
487 AMNESIA 270 0.0041
488 FLUID RETENTION 210 0.0041
489 TOOTH ABSCESS 42 0.0041
490 OXYGEN SATURATION DECREASED 231 0.0041
491 ACUTE CORONARY SYNDROME 34 0.0041
492 HEPATIC FUNCTION ABNORMAL 153 0.0041
493 CLOSTRIDIUM DIFFICILE INFECTION 89 0.0041
494 ONYCHOCLASIS 28 0.0041
495 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 195 0.0041
496 EPISTAXIS 303 0.0040
497 PANCREATITIS ACUTE 91 0.0040
498 PERICARDITIS 68 0.0040
499 SHOCK 93 0.0040
500 WHITE BLOOD CELL COUNT DECREASED 437 0.0040
501 PERICARDIAL EFFUSION 93 0.0040
502 HEAD INJURY 127 0.0040
503 SYNCOPE 401 0.0040
504 TRANSIENT ISCHAEMIC ATTACK 135 0.0040
505 VITAMIN D DECREASED 34 0.0040
506 MUSCULAR WEAKNESS 452 0.0040
507 PNEUMOTHORAX 63 0.0040
508 PALLOR 108 0.0040
509 LUNG NEOPLASM MALIGNANT 163 0.0040
510 DRUG-INDUCED LIVER INJURY 124 0.0039
511 COORDINATION ABNORMAL 55 0.0039
512 DIVERTICULUM 28 0.0039
513 INTERNAL HAEMORRHAGE 45 0.0039
514 NEUROTOXICITY 69 0.0039
515 EPILEPSY 120 0.0039
516 COVID-19 PNEUMONIA 46 0.0039
517 DISTURBANCE IN ATTENTION 210 0.0039
518 GINGIVAL BLEEDING 53 0.0039
519 PRODUCT DISTRIBUTION ISSUE 36 0.0039
520 SLEEP APNOEA SYNDROME 74 0.0039
521 PRESYNCOPE 94 0.0039
522 HYPOKINESIA 56 0.0039
523 HYPOGLYCAEMIA 187 0.0039
524 VENTRICULAR EXTRASYSTOLES 40 0.0038
525 STENT PLACEMENT 31 0.0038
526 EXOSTOSIS 35 0.0038
527 DEEP VEIN THROMBOSIS 249 0.0038
528 ARTERIOSCLEROSIS 36 0.0038
529 DEPRESSED MOOD 202 0.0038
530 DIZZINESS POSTURAL 37 0.0038
531 METABOLIC ACIDOSIS 122 0.0038
532 HYPERSOMNIA 109 0.0038
533 HYPERTHYROIDISM 55 0.0038
534 ABDOMINAL PAIN LOWER 96 0.0038
535 INFUSION SITE ERYTHEMA 32 0.0038
536 RESTLESS LEGS SYNDROME 69 0.0038
537 BLOOD PRESSURE DIASTOLIC DECREASED 28 0.0038
538 BLOOD IRON DECREASED 45 0.0038
539 HEMIPARESIS 64 0.0038
540 HYPERAESTHESIA 31 0.0038
541 ATRIAL FLUTTER 30 0.0038
542 HYPOTHYROIDISM 120 0.0038
543 LOSS OF CONSCIOUSNESS 480 0.0037
544 PLASMA CELL MYELOMA 146 0.0037
545 CHEST PAIN 693 0.0037
546 NEUROPATHY PERIPHERAL 354 0.0037
547 HAEMORRHAGIC STROKE 29 0.0037
548 ASTHENIA 1396 0.0037
549 RENAL INJURY 110 0.0037
550 STAPHYLOCOCCAL INFECTION 122 0.0037
551 CHOKING 72 0.0037
552 GASTRIC ULCER 70 0.0037
553 PULMONARY EMBOLISM 350 0.0037
554 APATHY 53 0.0036
555 WEIGHT DECREASED 1011 0.0036
556 DISEASE PROGRESSION 428 0.0036
557 PURPURA 32 0.0036
558 HAEMATOCHEZIA 199 0.0036
559 METASTASES TO BONE 59 0.0036
560 CHROMATURIA 81 0.0036
561 SPEECH DISORDER 188 0.0036
562 PNEUMOCYSTIS JIROVECII PNEUMONIA 36 0.0036
563 BEDRIDDEN 47 0.0036
564 HIP FRACTURE 115 0.0036
565 HAEMOLYTIC ANAEMIA 32 0.0036
566 IMPAIRED HEALING 117 0.0036
567 GASTRIC HAEMORRHAGE 41 0.0036
568 BLOOD GLUCOSE FLUCTUATION 39 0.0036
569 STATUS EPILEPTICUS 40 0.0035
570 DYSSTASIA 103 0.0035
571 DENTAL CARIES 39 0.0035
572 HALLUCINATION, AUDITORY 56 0.0035
573 ANOSMIA 51 0.0035
574 TRANSAMINASES INCREASED 78 0.0035
575 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
576 DYSPNOEA 1980 0.0035
577 MIOSIS 28 0.0035
578 ANKLE FRACTURE 54 0.0035
579 PNEUMONIA BACTERIAL 32 0.0035
580 AGITATION 256 0.0035
581 RHINITIS 28 0.0035
582 NERVOUS SYSTEM DISORDER 108 0.0035
583 ABNORMAL BEHAVIOUR 137 0.0035
584 SPINAL FRACTURE 69 0.0034
585 NAIL DISORDER 30 0.0034
586 TREMOR 569 0.0034
587 GASTROENTERITIS 50 0.0034
588 OSTEOMYELITIS 62 0.0034
589 COMA 163 0.0034
590 ANOREXIA 44 0.0034
591 ATRIAL FIBRILLATION 332 0.0034
592 FLATULENCE 193 0.0034
593 COLITIS 129 0.0034
594 ACUTE MYELOID LEUKAEMIA 53 0.0034
595 CONVULSION 194 0.0034
596 BACK PAIN 787 0.0034
597 RESPIRATORY RATE INCREASED 30 0.0034
598 CONTUSION 325 0.0034
599 SOMNOLENCE 677 0.0034
600 HOSPITALISATION 516 0.0034
601 NAUSEA 2655 0.0034
602 DYSTONIA 65 0.0033
603 BLISTER 188 0.0033
604 LIVER INJURY 82 0.0033
605 INFUSION SITE PAIN 43 0.0033
606 CARDIAC FAILURE 267 0.0033
607 HEPATITIS 85 0.0033
608 PANCREATITIS 175 0.0033
609 SKIN LACERATION 36 0.0033
610 BLOOD COUNT ABNORMAL 50 0.0033
611 NEPHROPATHY TOXIC 37 0.0033
612 HEPATIC CANCER 79 0.0033
613 BODY TEMPERATURE INCREASED 67 0.0033
614 SKIN FISSURES 64 0.0033
615 CYTOPENIA 40 0.0033
616 HERNIA 63 0.0033
617 ERUCTATION 63 0.0033
618 INTERVERTEBRAL DISC DEGENERATION 30 0.0032
619 RETCHING 69 0.0032
620 MUSCLE ATROPHY 41 0.0032
621 SEROTONIN SYNDROME 62 0.0032
622 FRACTURE 61 0.0032
623 CONDITION AGGRAVATED 975 0.0032
624 QUALITY OF LIFE DECREASED 43 0.0032
625 STOMATITIS 194 0.0032
626 MALIGNANT NEOPLASM PROGRESSION 326 0.0032
627 CARDIAC FAILURE CONGESTIVE 255 0.0032
628 ABDOMINAL PAIN UPPER 649 0.0031
629 CORONARY ARTERY DISEASE 95 0.0031
630 MEMORY IMPAIRMENT 428 0.0031
631 BLOOD URINE PRESENT 59 0.0031
632 PULMONARY ARTERIAL HYPERTENSION 45 0.0031
633 WOUND INFECTION 34 0.0031
634 DIARRHOEA 1998 0.0031
635 GASTROINTESTINAL PAIN 34 0.0031
636 BLOOD PRESSURE FLUCTUATION 74 0.0031
637 MUSCULOSKELETAL PAIN 161 0.0031
638 OSTEOARTHRITIS 130 0.0031
639 GOUT 55 0.0031
640 FEEDING DISORDER 62 0.0031
641 DEVICE OCCLUSION 43 0.0031
642 ACUTE RESPIRATORY DISTRESS SYNDROME 54 0.0031
643 RENAL DISORDER 142 0.0030
644 ANHEDONIA 80 0.0030
645 SWOLLEN TONGUE 95 0.0030
646 FULL BLOOD COUNT DECREASED 61 0.0030
647 ISCHAEMIC STROKE 54 0.0030
648 AKATHISIA 41 0.0030
649 BACTERIAL INFECTION 56 0.0030
650 GAIT DISTURBANCE 574 0.0030
651 BLOOD PRESSURE DECREASED 199 0.0030
652 CARDIO-RESPIRATORY ARREST 125 0.0030
653 CEREBRAL HAEMORRHAGE 107 0.0030
654 CYANOSIS 47 0.0030
655 JOINT RANGE OF MOTION DECREASED 40 0.0030
656 MICTURITION URGENCY 34 0.0030
657 VITAMIN D DEFICIENCY 29 0.0030
658 GALLBLADDER DISORDER 53 0.0030
659 BONE DISORDER 54 0.0030
660 THERAPY CESSATION 152 0.0030
661 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 69 0.0030
662 TOOTH INFECTION 39 0.0030
663 PERIPHERAL SWELLING 455 0.0030
664 LIMB INJURY 80 0.0029
665 SKIN ULCER 76 0.0029
666 PAIN IN JAW 83 0.0029
667 DIPLOPIA 76 0.0029
668 TYPE 2 DIABETES MELLITUS 98 0.0029
669 MALAISE 1275 0.0029
670 GAIT INABILITY 97 0.0029
671 GENERALISED TONIC-CLONIC SEIZURE 48 0.0029
672 PARANOIA 50 0.0029
673 ULCER 46 0.0029
674 FREQUENT BOWEL MOVEMENTS 78 0.0029
675 DYSPEPSIA 284 0.0029
676 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
677 PAIN 1765 0.0029
678 MANIA 47 0.0029
679 THIRST 51 0.0029
680 BONE MARROW FAILURE 58 0.0029
681 ACUTE MYOCARDIAL INFARCTION 84 0.0028
682 THINKING ABNORMAL 53 0.0028
683 RASH MACULO-PAPULAR 63 0.0028
684 WOUND 79 0.0028
685 SPINAL PAIN 33 0.0028
686 TASTE DISORDER 57 0.0028
687 BREAST CANCER METASTATIC 30 0.0028
688 NERVE INJURY 31 0.0028
689 TENDERNESS 29 0.0028
690 TENDONITIS 43 0.0028
691 BLOOD TEST ABNORMAL 39 0.0028
692 NECK PAIN 155 0.0028
693 OSTEOPOROSIS 114 0.0028
694 LOCALISED INFECTION 67 0.0028
695 AGEUSIA 69 0.0028
696 SWELLING FACE 180 0.0028
697 COUGH 773 0.0028
698 BLOOD PRESSURE SYSTOLIC INCREASED 53 0.0027
699 INTENTIONAL PRODUCT USE ISSUE 238 0.0027
700 FATIGUE 2113 0.0027
701 MUSCLE SPASMS 498 0.0027
702 INSOMNIA 722 0.0027
703 FOOT FRACTURE 51 0.0027
704 DECREASED ACTIVITY 29 0.0027
705 RESPIRATORY ARREST 74 0.0027
706 VIRAL INFECTION 89 0.0027
707 SKIN INFECTION 30 0.0027
708 INFECTION 386 0.0027
709 HEART RATE INCREASED 263 0.0027
710 SKIN DISORDER 88 0.0026
711 PROTEINURIA 50 0.0026
712 AGGRESSION 131 0.0026
713 LYMPHOPENIA 37 0.0026
714 HYPERHIDROSIS 337 0.0026
715 HEPATOCELLULAR INJURY 37 0.0026
716 TOOTH DISORDER 58 0.0026
717 LOWER LIMB FRACTURE 50 0.0026
718 SKIN LESION 71 0.0026
719 DRY MOUTH 210 0.0026
720 SLEEP DISORDER 181 0.0026
721 BURSITIS 31 0.0026
722 POST PROCEDURAL COMPLICATION 49 0.0025
723 PULMONARY MASS 38 0.0025
724 RASH PAPULAR 57 0.0025
725 NO THERAPEUTIC RESPONSE 31 0.0025
726 CEREBRAL INFARCTION 62 0.0025
727 PSYCHOMOTOR HYPERACTIVITY 42 0.0025
728 DIZZINESS 1262 0.0025
729 DIVERTICULITIS 70 0.0025
730 PREMATURE BABY 76 0.0025
731 VENTRICULAR FIBRILLATION 28 0.0025
732 CHEST DISCOMFORT 258 0.0025
733 RESPIRATORY TRACT CONGESTION 40 0.0025
734 UPPER LIMB FRACTURE 50 0.0025
735 ABASIA 62 0.0025
736 APHONIA 35 0.0025
737 NEPHROLITHIASIS 115 0.0025
738 FACE OEDEMA 42 0.0025
739 INJURY 175 0.0025
740 JOINT STIFFNESS 65 0.0025
741 VERTIGO 151 0.0025
742 RHINORRHOEA 160 0.0025
743 NEOPLASM PROGRESSION 86 0.0025
744 BRONCHITIS 182 0.0025
745 SCIATICA 39 0.0024
746 FEELING COLD 68 0.0024
747 CARDIOVASCULAR DISORDER 62 0.0024
748 ANGIOEDEMA 108 0.0024
749 ABDOMINAL DISCOMFORT 405 0.0024
750 HYPERTENSION 511 0.0024
751 BLINDNESS 98 0.0024
752 PERIPHERAL COLDNESS 33 0.0024
753 CHILLS 281 0.0024
754 PROSTATIC SPECIFIC ANTIGEN INCREASED 33 0.0024
755 BONE PAIN 140 0.0024
756 OSTEONECROSIS OF JAW 59 0.0024
757 PAIN OF SKIN 64 0.0024
758 PARALYSIS 34 0.0024
759 TOOTHACHE 43 0.0024
760 BASAL CELL CARCINOMA 37 0.0024
761 MOVEMENT DISORDER 76 0.0024
762 MASS 33 0.0024
763 DEATH 2030 0.0024
764 LACRIMATION INCREASED 71 0.0023
765 LYMPHADENOPATHY 83 0.0023
766 RASH PRURITIC 127 0.0023
767 SOPOR 31 0.0023
768 OBESITY 37 0.0023
769 EAR PAIN 45 0.0023
770 PAIN IN EXTREMITY 679 0.0023
771 ORAL DISCOMFORT 32 0.0023
772 ARRHYTHMIA 109 0.0023
773 NIGHT SWEATS 74 0.0023
774 UNEVALUABLE EVENT 173 0.0023
775 RASH ERYTHEMATOUS 109 0.0023
776 DEPRESSION 518 0.0023
777 DYSPHONIA 133 0.0023
778 CYST 28 0.0023
779 PALPITATIONS 264 0.0023
780 SENSORY DISTURBANCE 36 0.0022
781 PHOTOSENSITIVITY REACTION 37 0.0022
782 IRRITABILITY 134 0.0022
783 DEAFNESS 58 0.0022
784 CONTRAINDICATED PRODUCT ADMINISTERED 67 0.0022
785 PELVIC PAIN 40 0.0022
786 SKIN DISCOLOURATION 101 0.0022
787 PULMONARY FIBROSIS 42 0.0022
788 LIVER FUNCTION TEST INCREASED 47 0.0022
789 ANXIETY 623 0.0022
790 NASAL CONGESTION 128 0.0022
791 INTERSTITIAL LUNG DISEASE 105 0.0022
792 HEART RATE IRREGULAR 49 0.0022
793 CYSTITIS 69 0.0022
794 DIABETES MELLITUS 165 0.0022
795 PARAESTHESIA 340 0.0022
796 ASTHMA 244 0.0022
797 CONJUNCTIVITIS 40 0.0022
798 ANAPHYLACTIC REACTION 119 0.0022
799 DIABETES MELLITUS INADEQUATE CONTROL 38 0.0021
800 RESPIRATORY DISORDER 64 0.0021
801 POOR QUALITY SLEEP 46 0.0021
802 TINNITUS 98 0.0021
803 LIMB DISCOMFORT 66 0.0021
804 EYE PRURITUS 71 0.0021
805 BLOOD PRESSURE ABNORMAL 42 0.0021
806 THROMBOSIS 168 0.0021
807 HAEMORRHAGE 218 0.0021
808 GASTROINTESTINAL DISORDER 186 0.0021
809 DRUG EXPOSURE DURING PREGNANCY 70 0.0021
810 NIGHTMARE 71 0.0020
811 GASTROENTERITIS VIRAL 37 0.0020
812 BLOOD GLUCOSE DECREASED 98 0.0020
813 MEDICATION ERROR 113 0.0020
814 HEADACHE 1274 0.0020
815 HYPOAESTHESIA 304 0.0020
816 MUSCULOSKELETAL STIFFNESS 177 0.0020
817 PRODUCT AVAILABILITY ISSUE 46 0.0020
818 ACTIVITIES OF DAILY LIVING IMPAIRED 40 0.0020
819 MYOCARDIAL INFARCTION 352 0.0020
820 FIBROMYALGIA 49 0.0020
821 IMMUNODEFICIENCY 30 0.0020
822 FUNGAL INFECTION 67 0.0020
823 DERMATITIS 42 0.0020
824 LUNG DISORDER 98 0.0020
825 POLLAKIURIA 83 0.0020
826 TARDIVE DYSKINESIA 56 0.0020
827 BRONCHOSPASM 28 0.0020
828 IRRITABLE BOWEL SYNDROME 42 0.0020
829 DIABETIC KETOACIDOSIS 47 0.0020
830 BLOOD PRESSURE INCREASED 299 0.0020
831 OFF LABEL USE 1703 0.0019
832 RASH GENERALISED 50 0.0019
833 DRUG PRESCRIBING ERROR 37 0.0019
834 CEREBROVASCULAR ACCIDENT 326 0.0019
835 WEIGHT INCREASED 430 0.0019
836 ABNORMAL DREAMS 53 0.0019
837 SICKLE CELL ANAEMIA WITH CRISIS 30 0.0019
838 PRODUCT USE IN UNAPPROVED INDICATION 468 0.0019
839 EMOTIONAL DISORDER 58 0.0019
840 SWELLING 176 0.0019
841 HEART RATE DECREASED 66 0.0019
842 COLD SWEAT 33 0.0019
843 OROPHARYNGEAL PAIN 173 0.0019
844 BRAIN FOG 29 0.0018
845 INFLUENZA 206 0.0018
846 CATARACT 110 0.0018
847 ARTHRALGIA 767 0.0018
848 PRODUCT USE COMPLAINT 29 0.0018
849 ACCIDENTAL OVERDOSE 67 0.0018
850 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
851 ABSCESS 29 0.0018
852 SCAR 31 0.0018
853 RASH 785 0.0018
854 COVID-19 313 0.0018
855 BLOOD GLUCOSE INCREASED 335 0.0018
856 MYALGIA 301 0.0018
857 MENTAL DISORDER 77 0.0018
858 ROAD TRAFFIC ACCIDENT 74 0.0018
859 PHOTOPHOBIA 33 0.0018
860 JOINT SWELLING 211 0.0017
861 PRURITUS 671 0.0017
862 DRUG INTOLERANCE 168 0.0017
863 KIDNEY INFECTION 34 0.0017
864 DYSGEUSIA 128 0.0017
865 PANCREATIC CARCINOMA 49 0.0017
866 HEAD DISCOMFORT 30 0.0017
867 DRUG ERUPTION 30 0.0017
868 INFUSION RELATED REACTION 112 0.0017
869 TOOTH LOSS 35 0.0017
870 RASH MACULAR 59 0.0017
871 FEELING ABNORMAL 403 0.0017
872 FEMUR FRACTURE 52 0.0017
873 HOT FLUSH 125 0.0017
874 VISION BLURRED 227 0.0017
875 ORAL HERPES 32 0.0016
876 MIGRAINE 156 0.0016
877 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
878 PRODUCT ADMINISTRATION ERROR 33 0.0016
879 GASTRIC DISORDER 56 0.0016
880 OVERDOSE 351 0.0016
881 PRODUCT USE ISSUE 305 0.0016
882 INCREASED APPETITE 31 0.0016
883 DISEASE RECURRENCE 77 0.0016
884 ILL-DEFINED DISORDER 98 0.0016
885 ECZEMA 84 0.0016
886 INTENTIONAL DOSE OMISSION 45 0.0016
887 EXTRAPYRAMIDAL DISORDER 39 0.0016
888 INFLAMMATION 81 0.0016
889 HERPES ZOSTER 90 0.0016
890 SINUS DISORDER 31 0.0016
891 LABORATORY TEST ABNORMAL 46 0.0016
892 INTENTIONAL PRODUCT MISUSE 136 0.0016
893 DRUG ABUSE 126 0.0015
894 NASOPHARYNGITIS 277 0.0015
895 JOINT INJURY 32 0.0015
896 FLUSHING 152 0.0015
897 HYPOACUSIS 64 0.0015
898 NEOPLASM MALIGNANT 99 0.0015
899 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
900 INFLUENZA LIKE ILLNESS 122 0.0015
901 EYE SWELLING 55 0.0015
902 VISUAL IMPAIRMENT 183 0.0015
903 VISUAL ACUITY REDUCED 49 0.0015
904 SUICIDAL IDEATION 135 0.0015
905 MUSCULOSKELETAL DISORDER 28 0.0015
906 DISABILITY 29 0.0015
907 DRUG ADMINISTRATION ERROR 45 0.0015
908 PRESCRIBED OVERDOSE 28 0.0014
909 DRUG DOSE OMISSION 239 0.0014
910 DRY SKIN 191 0.0014
911 GLOSSODYNIA 32 0.0014
912 THERAPEUTIC RESPONSE UNEXPECTED 64 0.0014
913 FEAR 38 0.0014
914 SKIN CANCER 30 0.0014
915 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76 0.0014
916 NERVOUSNESS 72 0.0014
917 ERYTHEMA 283 0.0014
918 FEELING HOT 84 0.0014
919 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 97 0.0014
920 MYELOSUPPRESSION 49 0.0014
921 ANGER 46 0.0014
922 ALOPECIA 266 0.0014
923 EAR INFECTION 36 0.0014
924 BLOOD CHOLESTEROL INCREASED 63 0.0014
925 VAGINAL HAEMORRHAGE 58 0.0013
926 WITHDRAWAL SYNDROME 56 0.0013
927 ILLNESS 137 0.0013
928 SINUSITIS 136 0.0013
929 BURNING SENSATION 93 0.0013
930 PANIC ATTACK 48 0.0013
931 CARDIAC DISORDER 121 0.0013
932 PRODUCT DOSE OMISSION 84 0.0013
933 EYE DISORDER 42 0.0013
934 ADVERSE DRUG REACTION 114 0.0013
935 SKIN EXFOLIATION 107 0.0013
936 CRYING 46 0.0013
937 THERAPY NON-RESPONDER 56 0.0012
938 DISCOMFORT 75 0.0012
939 THROAT IRRITATION 55 0.0012
940 THROAT TIGHTNESS 33 0.0012
941 OSTEONECROSIS 40 0.0012
942 SURGERY 71 0.0012
943 FOETAL EXPOSURE DURING PREGNANCY 98 0.0012
944 MOOD SWINGS 38 0.0012
945 ARTHROPATHY 66 0.0012
946 ARTHRITIS 93 0.0012
947 DEVICE DISLOCATION 51 0.0012
948 MULTIPLE SCLEROSIS 56 0.0012
949 ERECTILE DYSFUNCTION 30 0.0012
950 PROCEDURAL PAIN 32 0.0012
951 HYPERSENSITIVITY 213 0.0011
952 EMOTIONAL DISTRESS 138 0.0011
953 DRUG RESISTANCE 29 0.0011
954 DRY EYE 56 0.0011
955 EYE PAIN 63 0.0011
956 TREATMENT FAILURE 92 0.0011
957 OCULAR HYPERAEMIA 52 0.0011
958 URTICARIA 181 0.0011
959 PHARMACEUTICAL PRODUCT COMPLAINT 28 0.0011
960 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39 0.0011
961 PRODUCT DOSE OMISSION ISSUE 309 0.0010
962 ADVERSE EVENT 91 0.0010
963 MULTIPLE SCLEROSIS RELAPSE 65 0.0009
964 DRUG INEFFECTIVE 1212 0.0009
965 UNDERDOSE 66 0.0009
966 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 161 0.0009
967 INTENTIONAL OVERDOSE 57 0.0009
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 60 0.0008
969 THERAPEUTIC RESPONSE DECREASED 51 0.0008
970 SUICIDE ATTEMPT 50 0.0008
971 DRUG WITHDRAWAL SYNDROME 66 0.0008
972 MATERNAL EXPOSURE DURING PREGNANCY 67 0.0008
973 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
974 DEVICE ISSUE 66 0.0007
975 RHEUMATOID ARTHRITIS 80 0.0007
976 PSORIASIS 92 0.0007
977 INCORRECT DOSE ADMINISTERED 154 0.0007
978 DRUG EFFECT DECREASED 34 0.0006
979 PROSTATE CANCER 42 0.0005
980 EYE IRRITATION 29 0.0005
981 PRODUCT SUBSTITUTION ISSUE 29 0.0005
982 ACNE 38 0.0005
983 PRODUCT QUALITY ISSUE 66 0.0005
984 COMPLETED SUICIDE 40 0.0005
985 NO ADVERSE EVENT 85 0.0005
986 BREAST CANCER 43 0.0005
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90 0.0004
988 SKIN BURNING SENSATION 30 0.0004
989 DEVICE MALFUNCTION 29 0.0004
990 DRUG DEPENDENCE 62 0.0004
991 INJECTION SITE ERYTHEMA 35 0.0003
992 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
993 INJECTION SITE PAIN 81 0.0003